Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors

BIN-CHI LIAOBai Y.-YJIH-HSIANG LEECHIA-CHI LINSHU-YUNG LINYEE-FAN LEECHAO-CHI HOJIN-YUAN SHIHYEUN-CHUNG CHANGCHONG-JEN YUCHIH-HSIN YANGPAN-CHYR YANG2022-09-152022-09-1520180929-6646https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019018044&doi=10.1016%2fj.jfma.2017.04.018&partnerID=40&md5=5b5df01d40193525c186e40b86327edfhttps://scholars.lib.ntu.edu.tw/handle/123456789/620269[SDGs]SDG3Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitorsjournal article10.1016/j.jfma.2017.04.018284996412-s2.0-85019018044